WealthCare Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.68M | Buy |
12,938
+926
| +8% | +$120K | 0.6% | 46 |
|
2025
Q1 | $1.41M | Buy |
12,012
+1,664
| +16% | +$195K | 0.6% | 49 |
|
2024
Q4 | $1.38M | Buy |
10,348
+96
| +0.9% | +$12.8K | 0.6% | 43 |
|
2024
Q3 | $1.46M | Buy |
10,252
+281
| +3% | +$40K | 0.64% | 42 |
|
2024
Q2 | $1.37M | Buy |
9,971
+401
| +4% | +$55K | 0.64% | 42 |
|
2024
Q1 | $1.31M | Buy |
9,570
+527
| +6% | +$72.3K | 0.63% | 40 |
|
2023
Q4 | $1.26M | Buy |
9,043
+343
| +4% | +$47.8K | 0.69% | 40 |
|
2023
Q3 | $1.05M | Buy |
8,700
+425
| +5% | +$51.3K | 0.64% | 41 |
|
2023
Q2 | $1.05M | Buy |
8,275
+94
| +1% | +$11.9K | 0.63% | 42 |
|
2023
Q1 | $1.06M | Buy |
8,181
+528
| +7% | +$68.2K | 0.64% | 45 |
|
2022
Q4 | $1M | Buy |
7,653
+265
| +4% | +$34.8K | 0.68% | 39 |
|
2022
Q3 | $864K | Buy |
7,388
+204
| +3% | +$23.9K | 0.71% | 43 |
|
2022
Q2 | $845K | Buy |
7,184
+1,451
| +25% | +$171K | 0.72% | 44 |
|
2022
Q1 | $760K | Sell |
5,733
-576
| -9% | -$76.4K | 0.68% | 45 |
|
2021
Q4 | $963K | Buy |
+6,309
| New | +$963K | 0.93% | 32 |
|